Literature DB >> 28198686

Severely frail elderly patients do not need lipid-lowering drugs.

Laurie Herzig Mallery1, Paige Moorhouse2, Pam McLean Veysey3, Michael Allen4, Isobel Fleming4.   

Abstract

After performing a systematic review, members of the Palliative and Therapeutic Harmonization (PATH) program and the Dalhousie Academic Detailing Service found that evidence does not support lipid-lowering therapy for severely frail elderly patients.
Copyright © 2017 Cleveland Clinic.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28198686     DOI： 10.3949/ccjm.84a.15114

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  3 in total

Review 1.  The Frail Depressed Patient: A Narrative Review on Treatment Challenges.

Authors:  Ivan Aprahamian; Marcus K Borges; Denise J C Hanssen; Hans W Jeuring; Richard C Oude Voshaar
Journal:  Clin Interv Aging       Date:  2022-06-22       Impact factor: 3.829

2.  Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany.

Authors:  Christian Rausch; Falk Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  2020-03-26       Impact factor: 2.953

3.  Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.

Authors:  Laurie Mallery; Tanya MacLeod; Michael Allen; Pamela McLean-Veysey; Natasha Rodney-Cail; Evan Bezanson; Brian Steeves; Constance LeBlanc; Paige Moorhouse
Journal:  BMC Geriatr       Date:  2019-11-12       Impact factor: 3.921
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.